• Careers
  • Investors
  • News
  • Partnering
  • Contact Us
 
  • Home
  • Our Products
    • Recent Products
    • Consumer Products
    • Medical Devices & Diagnostics
    • Prescription Products
    • Product Coupons
  • Our Caring
    • Our Stories
    • Our Giving
    • Our Responsibility
    • Protecting Our People
    • Company Initiatives
  • Our Company
    • Our Credo Values
    • Our Management Approach
    • Our Citizenship
    • Corporate Governance
    • Company Structure
    • Our People & Diversity
    • Company Publications
    • Our History
  • News
    • All News
    • Corporate News
    • Product And Operating Company News
    • Financial News
    • Media Contacts
    • Product And Operating Company News Archive
  • Text Size
  • Text Only
  • Email to a Friend
  • Printer Friendly
  • RSS

Product and Operating Company News

Need to know more about a new skin care product? A new surgical device? A new pain relief medication? You can search here for the information you need from a Johnson & Johnson company.

< Prev | | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | .... 34 Next >
Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab

August 30, 2012

U.S. FDA Grants Priority Review Of ZYTIGA® (Abiraterone Acetate) sNDA For Treatment of Metastatic Castration-Resistant Prostate Cancer before Chemotherapy

August 29, 2012

FDA Approves NUCYNTA® ER (tapentadol) Extended-Release Oral Tablets for the Management of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy

August 29, 2012

Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis

August 23, 2012

The Makers of LISTERINE® Antiseptic and REACH® Products Support America’s ToothFairy® to Combat Pediatric Dental Disease– America’s #1 Chronic Childhood Illness

August 15, 2012

Johnson & Johnson Family of Consumer Companies Launches Ingredient Transparency Website for Baby and Beauty Products

August 15, 2012

< Prev | | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | .... 34 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Employees
  • Careers
  • Investors
  • News
  • Partnering
  • Contact Us
Johnson & Johnson
  • Home
  • Our Products
  • Our Caring
  • Our Company
  • All News
  • Corporate News
  • Product And Operating Company News
  • Financial News
  • Media Contacts
  • Product And Operating Company News Archive
  • Text Size
  • Graphic Version
  • Email to a Friend
  • Printer Friendly
  • RSS

Product and Operating Company News

Need to know more about a new skin care product? A new surgical device? A new pain relief medication? You can search here for the information you need from a Johnson & Johnson company.

This section contains multiple pages. Click on each page number to advance the page.
< Prev | | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | .... 34 Next >
Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab

August 30, 2012

U.S. FDA Grants Priority Review Of ZYTIGA® (Abiraterone Acetate) sNDA For Treatment of Metastatic Castration-Resistant Prostate Cancer before Chemotherapy

August 29, 2012

FDA Approves NUCYNTA® ER (tapentadol) Extended-Release Oral Tablets for the Management of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy

August 29, 2012

Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis

August 23, 2012

The Makers of LISTERINE® Antiseptic and REACH® Products Support America’s ToothFairy® to Combat Pediatric Dental Disease– America’s #1 Chronic Childhood Illness

August 15, 2012

Johnson & Johnson Family of Consumer Companies Launches Ingredient Transparency Website for Baby and Beauty Products

August 15, 2012

< Prev | | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | .... 34 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •